AU2019251091A1 - Application of PEDF-derived short peptides in tendon healing - Google Patents

Application of PEDF-derived short peptides in tendon healing Download PDF

Info

Publication number
AU2019251091A1
AU2019251091A1 AU2019251091A AU2019251091A AU2019251091A1 AU 2019251091 A1 AU2019251091 A1 AU 2019251091A1 AU 2019251091 A AU2019251091 A AU 2019251091A AU 2019251091 A AU2019251091 A AU 2019251091A AU 2019251091 A1 AU2019251091 A1 AU 2019251091A1
Authority
AU
Australia
Prior art keywords
pdsp
tendon
pedf
mer
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019251091A
Other languages
English (en)
Inventor
Tsung-Chuan Ho
Frank Wen-Chi LEE
Yuan-Ming Lee
Yeou-Ping Tsao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brim Biotechnology Inc
Original Assignee
Brim Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brim Biotechnology Inc filed Critical Brim Biotechnology Inc
Publication of AU2019251091A1 publication Critical patent/AU2019251091A1/en
Priority to AU2025201569A priority Critical patent/AU2025201569A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2019251091A 2018-04-08 2019-04-08 Application of PEDF-derived short peptides in tendon healing Abandoned AU2019251091A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2025201569A AU2025201569A1 (en) 2018-04-08 2025-03-04 Application of pedf-derived short peptides in tendon healing

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862654466P 2018-04-08 2018-04-08
US62/654,466 2018-04-08
PCT/US2019/026307 WO2019199661A1 (en) 2018-04-08 2019-04-08 Application of pedf-derived short peptides in tendon healing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2025201569A Division AU2025201569A1 (en) 2018-04-08 2025-03-04 Application of pedf-derived short peptides in tendon healing

Publications (1)

Publication Number Publication Date
AU2019251091A1 true AU2019251091A1 (en) 2020-11-26

Family

ID=68163751

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2019251091A Abandoned AU2019251091A1 (en) 2018-04-08 2019-04-08 Application of PEDF-derived short peptides in tendon healing
AU2025201569A Pending AU2025201569A1 (en) 2018-04-08 2025-03-04 Application of pedf-derived short peptides in tendon healing

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2025201569A Pending AU2025201569A1 (en) 2018-04-08 2025-03-04 Application of pedf-derived short peptides in tendon healing

Country Status (10)

Country Link
US (1) US20210244791A1 (cg-RX-API-DMAC7.html)
EP (1) EP3761959A4 (cg-RX-API-DMAC7.html)
JP (2) JP7481261B2 (cg-RX-API-DMAC7.html)
KR (1) KR20200142521A (cg-RX-API-DMAC7.html)
CN (1) CN113038929A (cg-RX-API-DMAC7.html)
AU (2) AU2019251091A1 (cg-RX-API-DMAC7.html)
EA (1) EA202092368A1 (cg-RX-API-DMAC7.html)
IL (1) IL277689B2 (cg-RX-API-DMAC7.html)
TW (1) TWI902659B (cg-RX-API-DMAC7.html)
WO (1) WO2019199661A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210244791A1 (en) * 2018-04-08 2021-08-12 Brim Biotechnology, Inc. Application of pedf-derived short peptides in tendon healing

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1924276A4 (en) * 2005-08-05 2009-07-22 Araim Pharmaceuticals Inc Antiperspirant peptides and their uses
EP1986676A4 (en) * 2006-02-15 2009-11-04 Univ Yale Inc COMPOSITIONS AND METHODS FOR USE OF PEDF (PIGMENT-BASED EPITHELIC DERIVED FACTOR) PEPTIDE FRAGMENTS
ES2329636B2 (es) * 2006-02-17 2010-07-26 Universitat De Valencia, Estudi General (Participa Con El 70%) Uso del factor pedf para inducir la auto-renovacion de celulas madre.
EP2508196B1 (en) * 2011-03-23 2018-09-26 Mackay Memorial Hospital Use of PEDF-derived polypeptides for promoting stem cells proliferation and wound healing
AU2012387503B2 (en) * 2012-08-09 2016-11-03 Mackay Memorial Hospital Use of PEDF-derived polypeptides for promoting muscle or tendon regeneration or arteriogenesis
TWI491616B (zh) * 2012-08-09 2015-07-11 Mackay Memorial Hospital 色素上皮衍生因子衍生之多胜肽於促進肌肉或肌腱再生或動脈血管生成之用途
KR20230169375A (ko) * 2016-10-07 2023-12-15 브림 바이오테크놀로지, 인코퍼레이티드 Pedf-유래 짧은 펩타이드를 포함하는 조성물 및 그것의 사용
US20210244791A1 (en) * 2018-04-08 2021-08-12 Brim Biotechnology, Inc. Application of pedf-derived short peptides in tendon healing

Also Published As

Publication number Publication date
IL277689B1 (en) 2024-08-01
TW202010513A (zh) 2020-03-16
JP7481261B2 (ja) 2024-05-10
CN113038929A (zh) 2021-06-25
TWI902659B (zh) 2025-11-01
IL277689A (en) 2020-11-30
IL277689B2 (en) 2024-12-01
EA202092368A1 (ru) 2021-01-18
AU2025201569A1 (en) 2025-05-22
US20210244791A1 (en) 2021-08-12
JP2024054273A (ja) 2024-04-16
EP3761959A4 (en) 2022-03-02
WO2019199661A1 (en) 2019-10-17
EP3761959A1 (en) 2021-01-13
JP2021521113A (ja) 2021-08-26
KR20200142521A (ko) 2020-12-22

Similar Documents

Publication Publication Date Title
US9884012B2 (en) Use of PEDF-derived polypeptides for promoting muscle or tendon regeneration or arteriogenesis
Ho et al. PEDF-derived peptide promotes tendon regeneration through its mitogenic effect on tendon stem/progenitor cells
JP2024054274A (ja) 変形性関節症の治療におけるpedf由来短鎖ペプチドの使用
Ashraf et al. RHEB gene therapy maintains the chondrogenic characteristics and protects cartilage tissue from degenerative damage during experimental murine osteoarthritis
Qiu et al. Bone marrow mesenchymal stem cells overexpressing FGF-2 loaded onto a decellularized extracellular matrix hydrogel for the treatment of osteoarthritis
JP2024054273A (ja) 腱治癒に対するpedf由来短鎖ペプチドの使用
KR101736280B1 (ko) 관절염 예방 또는 치료용 약학적 조성물
TWI491616B (zh) 色素上皮衍生因子衍生之多胜肽於促進肌肉或肌腱再生或動脈血管生成之用途
JP2018115138A (ja) テトラペプチド−3 gekgまたはペンタペプチド−3 gekgfにより変形性関節症を治療するための新規用途
JP6489486B2 (ja) ペンタペプチド/ヘキサペプチドにより変形性関節症を治療するための新規用途
TW201801741A (zh) 四/五胜肽gekg(f)於治療退化性關節炎之用途
JP2017165745A (ja) 筋肉若しくは腱再生又は動脈形成を促進するためのpedf由来のポリペプチドの使用
Ho et al. Articles in PresS. Am J Physiol Cell Physiol (June 3, 2015). doi: 10.1152/ajpcell. 00344.2014
TW201801742A (zh) 五/六胜肽kttks(f)於治療退化性關節炎之用途

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted